Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12

Author： Van Hoecke C.   Fu D.   De Grave D.   Voet P.   Lebacq E.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.16, Iss.17, 1998-10, pp. : 1688-1692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine

By Vodopija R.   Lafont M.   Baklaic Z.   Ljubicic M.   Svjetlicic M.   Vodopija I.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 571-574

Elsevier

Access to resources Recommend Favorite

Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants

By Johnson C.E.   Darbari A.   Darbari D.S.   Nalin D.   Whitwell J.   Chui L.W.   Cleves M.A.   Kumar M.L.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2411-2415

Elsevier

Access to resources Recommend Favorite

Measles vaccine immunogenicity and antibody persistence in 12- vs. 15-month-old infants

By Arya S.C.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 294-294

Elsevier

Access to resources Recommend Favorite

Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid

By Pittman P.R.   Hack D.   Mangiafico J.   Gibbs P.   McKee K.T.   Friedlander A.M.   Sjogren M.H.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2107-2115

Elsevier

Access to resources Recommend Favorite

Inducing immunological response to Borrelia burgdorferi using outer membrane protein A; for use as a Lyme disease oral recombinant vaccine

By Barbour A.G.   Luke C.J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 436-436

Elsevier

Access to resources Recommend Favorite